Interleukin 15 activity in the rectal mucose of inflammatory bowel disease

被引:89
作者
Sakai, T
Kusugami, K
Nishimura, H
Ando, T
Yamaguchi, T
Ohsuga, M
Ina, K
Enomoto, A
Kimura, Y
Yoshikai, Y
机构
[1] Nagoya Univ, Sch Med, Dept Internal Med 1, Res Inst Dis Mechanism & Control,Showa Ku, Nagoya, Aichi 466, Japan
[2] Nagoya Univ, Sch Med, Res Inst Dis Mechanism & Control, Lab Host Def & Germfree Life, Nagoya, Aichi 466, Japan
关键词
D O I
10.1016/S0016-5085(98)70430-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Interleukin (IL)-15 has been found to shave many immunoregulatory activities in lymphocytes with IL-2. The aim of this study was to investigate IL-15 activity in organ cultures, localization of IL-15 messenger RNA (mRNA), and proliferation of lamina propria mononuclear cells (LPMCs) in response to recombinant IL-15 using the mucosal tissues obtained from patients with inflammatory bower disease (IBD). Methods: The contents of IL-15, tumor necrosis factor alpha, and IL-2 in the culture supernatant of the rectal mucosal tissues were determined by an enzyme-linked immunosorbent assay. Expression of IL-15 mRNA was analyzed by in situ hybridization, and proliferative response of LPMCs to recombinant IL-15 was determined by [H-3]thymidine incorporation into DNA. Results: Significantly greater IL-15 activity was detected in active IBD, and this elevation was also observed in inactive ulcerative colitis. In contrast, greater tumor necrosis factor a activity was observed only in active IBD, and IL-2 was not detected in organ cultures. In situ hybridization showed IL-15 mRNA in macrophages and epithelial cells in active IBD specimens, and recombinant IL-15 induced a dose-dependent proliferative response in LPMCs. Conclusions: Mucosal IL-15 may be involved in the pathogenesis of IBD as one of the important mediators in activation of mucosal immune cells.
引用
收藏
页码:1237 / 1243
页数:7
相关论文
共 30 条
[1]  
ARMITAGE RJ, 1995, J IMMUNOL, V154, P483
[2]  
BREESE E, 1993, IMMUNOLOGY, V78, P127
[3]   INCREASED CONCENTRATIONS OF INTERLEUKIN 1-BETA, INTERLEUKIN-2, AND SOLUBLE INTERLEUKIN-2 RECEPTORS IN ENDOSCOPIC MUCOSAL BIOPSY SPECIMENS WITH ACTIVE INFLAMMATORY BOWEL-DISEASE [J].
BRYNSKOV, J ;
TVEDE, N ;
ANDERSEN, CB ;
VILIEN, M .
GUT, 1992, 33 (01) :55-58
[4]   DETECTION OF MESSENGER-RNAS FOR MACROPHAGE PRODUCTS IN INFLAMMATORY BOWEL-DISEASE BY INSITU HYBRIDIZATION [J].
CAPPELLO, M ;
KESHAV, S ;
PRINCE, C ;
JEWELL, DP ;
GORDON, S .
GUT, 1992, 33 (09) :1214-1219
[5]   INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR [J].
CARSON, WE ;
GIRI, JG ;
LINDEMANN, MJ ;
LINETT, ML ;
AHDIEH, M ;
PAXTON, R ;
ANDERSON, D ;
EISENMANN, J ;
GRABSTEIN, K ;
CALIGIURI, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1395-1403
[6]   DIFFERENTIAL EXPRESSION OF CD25 (INTERLEUKIN-2 RECEPTOR) ON LAMINA PROPRIA T-CELLS AND MACROPHAGES IN THE INTESTINAL LESIONS IN CROHNS-DISEASE AND ULCERATIVE-COLITIS [J].
CHOY, MY ;
WALKERSMITH, JA ;
WILLIAMS, CB ;
MACDONALD, TT .
GUT, 1990, 31 (12) :1365-1370
[7]  
FIOCCHI C, 1984, GASTROENTEROLOGY, V86, P734
[8]   CLONING OF A T-CELL GROWTH-FACTOR THAT INTERACTS WITH THE BETA-CHAIN OF THE INTERLEUKIN-2 RECEPTOR [J].
GRABSTEIN, KH ;
EISENMAN, J ;
SHANEBECK, K ;
RAUCH, C ;
SRINIVASAN, S ;
FUNG, V ;
BEERS, C ;
RICHARDSON, J ;
SCHOENBORN, MA ;
AHDIEH, M ;
JOHNSON, L ;
ALDERSON, MR ;
WATSON, JD ;
ANDERSON, DM ;
GIRI, JG .
SCIENCE, 1994, 264 (5161) :965-968
[9]  
HARUTA J, 1992, AM J GASTROENTEROL, V87, P448
[10]  
HARVEY RF, 1980, LANCET, V1, P514